Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | MMP13 | P45452 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TNKS | O95271 | 1/20 | 0.30 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21662944 | 0.77 | CA1 (0.36) | TNKSTNKS2 | |
| SCHEMBL3641821 | 0.68 | TNKS (0.33) | MAPTTP53RXFP1KDM4EALDH1A1 | |
| SCHEMBL21862373 | 0.66 | MAPT (0.40) | MAPTTP53KDM4ETNKSTNKS2 | |
| SCHEMBL30052514 | 0.65 | MAPT (0.48) | MAPTTP53KDM4EALDH1A1 | |
| SCHEMBL21201214 | 0.65 | MAPT (0.48) | MAPTTP53KDM4EALDH1A1 | |
| SCHEMBL3636775 | 0.63 | ALOX5 (0.43) | MAPTKDM4EALDH1A1TNKSTNKS2 | |
| SCHEMBL22311238 | 0.63 | PLK4 (0.43) | MAPTKDM4ETNKSTNKS2 | |
| SCHEMBL27449995 | 0.63 | GPR3 (0.40) | MAPTKDM4EALDH1A1TNKSTNKS2 | |
| SCHEMBL30422223 | 0.63 | ALOX5 (0.43) | MAPTKDM4EALDH1A1TNKSTNKS2 | |
| SCHEMBL23111300 | 0.62 | MAPT (0.43) | MAPTTP53RXFP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200039971-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2020-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200039971-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, CYP1A1 | MAPT 961/4885TP53 3162/4885RXFP1 4081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.